1. Home
  2. KE vs OVID Comparison

KE vs OVID Comparison

Compare KE & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$24.58

Market Cap

635.4M

Sector

Technology

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.46

Market Cap

522.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
OVID
Founded
1961
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
635.4M
522.6M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
KE
OVID
Price
$24.58
$2.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$28.00
$4.60
AVG Volume (30 Days)
128.5K
1.7M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.90
EPS
0.78
N/A
Revenue
$1,486,727,000.00
$7,252,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
$19.34
P/E Ratio
$31.13
N/A
Revenue Growth
N/A
1181.27
52 Week Low
$17.56
$0.27
52 Week High
$33.19
$3.11

Technical Indicators

Market Signals
Indicator
KE
OVID
Relative Strength Index (RSI) 44.67 42.00
Support Level $23.49 $1.95
Resistance Level $26.92 $2.72
Average True Range (ATR) 1.14 0.16
MACD -0.22 -0.06
Stochastic Oscillator 29.48 20.45

Price Performance

Historical Comparison
KE
OVID

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: